1. Home
  2. MRUS vs AHL Comparison

MRUS vs AHL Comparison

Compare MRUS & AHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • AHL
  • Stock Information
  • Founded
  • MRUS 2003
  • AHL 2002
  • Country
  • MRUS Netherlands
  • AHL Bermuda
  • Employees
  • MRUS 260
  • AHL N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • AHL Property-Casualty Insurers
  • Sector
  • MRUS Health Care
  • AHL Finance
  • Exchange
  • MRUS Nasdaq
  • AHL Nasdaq
  • Market Cap
  • MRUS 4.1B
  • AHL 3.2B
  • IPO Year
  • MRUS 2016
  • AHL 2025
  • Fundamental
  • Price
  • MRUS $53.11
  • AHL $31.64
  • Analyst Decision
  • MRUS Strong Buy
  • AHL Strong Buy
  • Analyst Count
  • MRUS 12
  • AHL 7
  • Target Price
  • MRUS $87.92
  • AHL $41.14
  • AVG Volume (30 Days)
  • MRUS 2.0M
  • AHL 165.9K
  • Earning Date
  • MRUS 07-31-2025
  • AHL 01-01-0001
  • Dividend Yield
  • MRUS N/A
  • AHL N/A
  • EPS Growth
  • MRUS N/A
  • AHL N/A
  • EPS
  • MRUS N/A
  • AHL 5.84
  • Revenue
  • MRUS $54,732,000.00
  • AHL $3,191,100,000.00
  • Revenue This Year
  • MRUS $75.57
  • AHL N/A
  • Revenue Next Year
  • MRUS $31.84
  • AHL N/A
  • P/E Ratio
  • MRUS N/A
  • AHL $5.44
  • Revenue Growth
  • MRUS 42.77
  • AHL 8.41
  • 52 Week Low
  • MRUS $33.19
  • AHL $30.86
  • 52 Week High
  • MRUS $62.98
  • AHL $36.10
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 53.18
  • AHL N/A
  • Support Level
  • MRUS $52.41
  • AHL N/A
  • Resistance Level
  • MRUS $54.59
  • AHL N/A
  • Average True Range (ATR)
  • MRUS 2.15
  • AHL 0.00
  • MACD
  • MRUS -0.77
  • AHL 0.00
  • Stochastic Oscillator
  • MRUS 7.62
  • AHL 0.00

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About AHL Aspen Insurance Holdings Limited Class A Ordinary Shares

Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.

Share on Social Networks: